Ukraine surrogacy: medical and donor requirements
The short answer
In Ukraine, surrogacy is not decided by a clinic or agency alone. The main medical conditions are in Ministry of Health Order No. 787 of 9 September 2013, the Procedure for the Use of Assisted Reproductive Technologies (ART Procedure). The official portal displays a revision dated 29 January 2025; recheck it before treatment.
Separate questions must be answered: whether a qualifying medical indication exists; whether the intended parent(s) and surrogate meet examination requirements; whether donor gametes fit the proposed genetic arrangement; whether written applications and consents are complete; and whether the clinic can lawfully provide the service. Meeting one condition does not satisfy the others.
This guide covers medical and donor requirements, not every issue of intended-parent eligibility, contract enforceability, birth registration, nationality, passports or the child’s departure from Ukraine. Those matters need separate legal review before the programme begins.
Which rules are binding law?
Order No. 787 is the main binding source: sections I–III cover ART access, examinations and contraindications; section V covers donor gametes and embryos; section VI covers surrogacy. It requires patient applications and examinations, sets medical indications and eligibility conditions, and specifies records and consents. ART must be provided by a healthcare facility licensed for medical practice, with the required equipment and medical staff.
Civil Code article 281(7) allows adults to receive ART treatment on medical indications under the legally prescribed procedure. Articles 42–43 of the Fundamentals of Ukrainian Legislation on Health Care govern medical intervention and informed patient consent for diagnosis, prevention and treatment; risky interventions are subject to statutory safeguards. Family Code article 123 separately addresses parentage after ART, including transfer of an embryo to another woman. A surrogacy agreement does not replace procedure-specific clinical consent.
These sources do different jobs: the ART Procedure sets clinical and programme conditions, health-care law addresses safety and consent, and the Family Code addresses parentage. A clinic may reasonably request additional tests, but should distinguish a specific legal requirement from a clinician’s case-specific assessment or internal policy.
When does Ukrainian law allow a surrogacy programme on medical grounds?
Section VI, point 6.2 of Order No. 787 identifies five medical indications for surrogacy:
- congenital or acquired absence of the uterus;
- uterine-cavity or cervical deformity caused by a congenital defect, surgery or benign tumour that makes carrying a pregnancy impossible;
- structural, morphological or anatomical endometrial changes causing loss of receptivity, or intrauterine adhesions that cannot be treated;
- a severe somatic disease in which pregnancy threatens the intended mother’s health or life, provided the disease does not affect the future child’s health; and
- four or more unsuccessful ART attempts where high-quality embryos were repeatedly obtained but transfer did not result in pregnancy.
These criteria do not guarantee success. Contraindications, current health and the suitability of the proposed ART method must also be assessed.
What medical screening is required?
Before ART, the patient must apply, undergo examination and complete appropriate investigations. The order lists baseline tests for women and men, plus additional tests when indicated. For a woman, the baseline list includes a therapist’s opinion on general somatic health and pregnancy contraindications; blood group and Rh factor; blood count and coagulation; blood tests for syphilis, HIV and hepatitis B/C (valid for six months if there are no clinical symptoms); IgM/IgG blood tests for toxoplasmosis, chlamydia, cytomegalovirus and rubella; vaginal, urethral and cervical smears; cervical cytology; gynaecological examination; pelvic ultrasound; and reproductive-hormone tests.
For a man, the baseline list includes blood group and Rh factor, tests for syphilis, HIV and hepatitis B/C (valid for six months if there are no clinical symptoms), semen analysis and lung fluorography. Depending on indications, the order lists specialist consultations, karyotyping, medical-genetic counselling, other molecular-genetic tests and selected hormone or sperm tests. Many additional tests are expressly indication-dependent, not automatically mandatory for everyone.
Do not confuse the standard ART examination with a universal genetic panel for every donor or the surrogate’s individual medical plan. Tests depend on the person, procedure, history and contraindications. Ask for a written, participant-specific list and the legal or medical basis for each item. Other indication-dependent examples include uterine/tubal assessment, colposcopy, endometrial biopsy, hormone and glucose tests, selected antibodies, ultrasound and biochemical blood work for women; for men, andrology review, TORCH-infection testing, hormone tests, sperm DNA-fragmentation analysis and the MAR test.
Contraindications and the multidisciplinary review
Appendix 30 to Order No. 787 lists contraindications for ART programmes treating female infertility, including diseases or conditions in which pregnancy is contraindicated. The list is detailed and may distinguish form, stage, severity and clinical circumstances. It should not be reduced to a rule that any diagnosis automatically excludes every patient.
Under point 1.10, as amended in 2024, a multidisciplinary consultation is provided for when no contraindications are found. It includes the medical director, treating doctor, therapist and obstetrician-gynaecologist; other specialists may join if needed. The consultation concludes whether an ART programme can be used, and the record is entered in the electronic health-care system as prescribed.
Ask for the relevant conclusion or medical record, which contraindications were assessed, whether another specialist is needed and whether the surrogacy indication is documented. A refusal may rest on medical risk, regulation or clinic policy; ask for written reasons.
Who may act as a surrogate?
Under point 6.4, a surrogate must be an adult woman with legal capacity, have her own healthy child, submit a voluntary written application in the prescribed form and have no medical contraindications. Point 6.3 requires the general ART examination and a psychiatric examination. Point 6.4 itself sets no separate numerical maximum age; this does not waive the general examination or contraindication rules.
Point 6.1 requires that the surrogate have no direct genetic relationship with the child. A close relative of the intended parents, including a mother, sister or cousin, may carry the pregnancy. At least one intended parent must have a genetic link to the child. A donor may provide one gamete, but the arrangement must still satisfy that rule; do not assume an embryo genetically unrelated to both intended parents qualifies.
A signed agreement alone does not establish medical suitability. The examination, psychiatric assessment, voluntary written application, proof of the surrogate’s own child and any required spouse consent are separate parts of the programme file.
Who may donate eggs or sperm?
For egg donation, point 5.5 sets the donor age at 18–36 years. The donor must have given birth to a healthy child, have no adverse phenotypic manifestations, be in satisfactory somatic health, have no hereditary disease or donation contraindication, and have none of the specified harmful habits: drug addiction, alcoholism or substance abuse. Permitted categories include anonymous voluntary donors, close relatives and ART patients who voluntarily donate part of their oocytes.
For sperm donation, points 5.11–5.14 set the age at 20–40 years and require that the donor already have a healthy child born. Adverse phenotypic findings, relevant somatic or hereditary disease, other contraindications, use of narcotic, psychotropic or toxic substances, and alcohol abuse exclude donation.
These criteria determine eligibility but do not guarantee a sample suits a particular recipient. The clinic must examine the donor, review laboratory results and document the donation. If age, child-history or health criteria are not met, ask for the legal basis before proceeding; marketing language does not replace the rule.
Donor testing, consent, anonymity and traceability
Order No. 787 requires written voluntary donor consent and specific records for gamete or embryo donation, including donor forms and logs for storage and use of biological material. An egg-donor record has fields for karyotype, cystic-fibrosis carrier status, fragile-X testing and other DNA tests. A form field alone does not prove every listed genetic test is universally mandatory; ask which tests are required by law, indicated by the medical history or part of clinic policy.
Where informed consent is signed for donation of oocytes, sperm or reproductive tissue for preservation, point 2.3 also requires collection of an additional 1–5 ml of whole blood and 10 ml of plasma, frozen at −20°C for further genetic tests and PCR checks for syphilis, HIV and hepatitis B/C. Confirm the precise scope for the participant and material concerned.
The order applies the IVF/ART examination scope to donors of sperm and oocytes and to recipients of donor embryos, oocytes and sperm. For donor sperm, section V, point 5.20 requires use of sperm that was cryopreserved in advance and thawed before ART, after repeat negative tests for HIV, syphilis and hepatitis B/C; it may not be used earlier than six months after cryopreservation. Point 4.6 states the corresponding rule separately for intrauterine insemination. Check the cryopreservation date, repeat-test results and clinic records.
A narrower route applies when repeat infection testing of cryopreserved donor sperm is impossible: one vial from the frozen portion may be retested by PCR for syphilis, HIV and hepatitis B/C. If PCR results are negative, the tested portion may be used as safe donor material without standard quarantine. This is a specific exception, not a general waiver of screening; the clinic should document why it applies and which portion was tested.
Recipients may request a donor’s phenotypic profile. Order No. 787 expressly includes close relatives among permitted oocyte-donor categories, while the sperm-donor selection rule refers to an anonymous donor; do not assume that a known or non-anonymous arrangement is permitted for every type of gamete. Anonymity does not mean that no medical record exists: coded records and traceability are required. If a known donor is proposed, ask the clinic to identify the exact legal basis and explain how consent, confidentiality, records and access to information will be handled.
Documents and a practical sequence
Before treatment, assemble the programme file. Under section VI, point 6.10, the surrogate’s documents include her application, a passport copy, marriage or divorce certificate (except for a single woman), birth certificate(s) of her child or children, and her husband’s consent unless she is single. Point 6.11 lists the intended spouses’ documents: an ART application, passport copies, a marriage certificate and a notarised copy of the joint written agreement with the surrogate. Point 6.1 expressly refers to the spouses “(or one of the intended parents)” when setting the genetic-link condition. However, points 6.9 and 6.11 describe birth registration and the document list in terms of the intended spouses. The wording therefore supports the genetic-link condition being met by one intended parent, but it does not by itself settle the complete documentation or birth-registration route for a single intended parent. If a single-parent arrangement is proposed, obtain a specific written opinion from Ukrainian counsel and written confirmation from the clinic and the competent registration authority before treatment.
The file should also contain participant-specific medical results and any required multidisciplinary conclusion. Where donor gametes are used, add the relevant donor consents, recipient request(s), donor questionnaire/personal card, and records for storage and use of biological material. For the birth-registration route in point 6.9, the documents include the surrogate’s notarised statement consenting to registration of the intended spouses as parents and a certificate of genetic relationship between the mother or father and the fetus. Do not assume that this route resolves a different family-status or cross-border situation; obtain separate advice on registration, foreign recognition, nationality and travel.
Practical sequence: (1) obtain the current Order No. 787 and confirm the indication; (2) request each participant’s mandatory and indication-dependent test list; (3) resolve contraindications and obtain the multidisciplinary conclusion if required; (4) confirm the genetic arrangement before selecting donor material; (5) complete prescribed consents and documents; and (6) keep copies of the clinic protocol, results and signed forms. Do not leave donor or genetic-link questions until after embryo creation or transfer.
Law versus clinic policy: a decision matrix
Use this matrix to distinguish the binding rule from the clinic’s operational decision:
A clinic may request additional testing when clinically justified, for example because of family history, infection risk or a prior abnormal result. It should explain whether the request comes from regulation, an individual medical assessment or internal protocol, and how an abnormal result affects eligibility, timing, cost and treatment options. Do not accept “the law requires it” without a specific provision or written protocol.
| Question | Binding rule in the order | What to verify with the clinic |
|---|---|---|
| Medical indication | One of the five indications in point 6.2 must apply. | Exact clause and supporting medical record. |
| Surrogate | Adult, legally capable, own healthy child, written voluntary application, no contraindications and psychiatric assessment. | Evidence for each condition and any further assessment. |
| Donor ages | Egg donor: 18–36; sperm donor: 20–40, plus other eligibility criteria. | Age, medical history, eligibility record and consent. |
| Extra genetic tests | Differentiate baseline tests, tests required by an indication and clinic policy. | Written reason, legal clause or clinical basis, and consequences. |
What to request before signing or paying
Before signing or paying, request written answers to these questions:
- Which point of Order No. 787 supports the medical indication in this case?
- Which tests are mandatory for each participant, which are required only if indicated, and which are additional clinic requirements?
- Which contraindications were assessed, and is a multidisciplinary conclusion required or already recorded?
- Does the donor arrangement preserve the rule that at least one intended parent has a genetic link to the child and the surrogate does not?
- How are donor eligibility, infection-screening dates, consents, coding and traceability documented? If a quarantine exception is used, which rule and PCR result support it?
- Which documents need to be notarised, who keeps the originals, and what happens if a test, consent or document is missing or needs updating?
Obtain a current written checklist from the treating doctor and clinic; have Ukrainian counsel review unresolved legal consequences before embryo transfer. The official portal showed Order No. 787 revised 29 January 2025; recheck the current text and clinic protocol before deciding.
Sources and legal texts
- Про затвердження Порядку застосування допоміжних репродуктивних технологій в Україні, наказ МОЗ України № 787 від 09.09.2013. Official legal text (Ukrainian); current revision shown by the portal as 29 January 2025.
- Сімейний кодекс України, стаття 123. Official legal text (Ukrainian), Article 123 on origin of a child born through ART.
- Основи законодавства України про охорону здоров’я, статті 42–43. Official legal text (Ukrainian), Articles 42–43 on medical intervention and patient consent.
- Цивільний кодекс України, стаття 281(7). Official legal text (Ukrainian), Article 281(7) on ART treatment on medical indications.
